Oncolytics BiotechONCY +3.00%31 FCF Yield % is -19.84 as of Jun. 29, 2026. GuruFocus rates ONCY with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 1,415 Biotechnology companies, Oncolytics Biotech ranks worse than 66.64% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Oncolytics Biotech FCF Yield % Related Terms
Oncolytics Biotech FCF Yield % Historical Data
* Premium members only.
The historical data trend for Oncolytics Biotech's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Oncolytics Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oncolytics Biotech FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oncolytics Biotech's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Oncolytics Biotech's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oncolytics Biotech (ONCY) has a FCF Yield % of -19.84 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Oncolytics Biotech and its competitors. According to the industry distribution chart, Oncolytics Biotech ranks #943 out of 1415 companies in the Biotechnology industry, placing it in the top 66.6%.
Is Oncolytics Biotech's FCF Yield % too high?
Oncolytics Biotech's current FCF Yield % is -19.84. Based on the distribution chart, Oncolytics Biotech ranks #943 out of 1415 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oncolytics Biotech has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Oncolytics Biotech's FCF Yield % compare to VRCA and ENGN?
According to the Biotechnology industry distribution chart, Oncolytics Biotech ranks #943 out of 1415 companies for FCF Yield %. This places Oncolytics Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Oncolytics Biotech and its competitors. Oncolytics Biotech's current FCF Yield % is -19.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncolytics Biotech stock overvalued right now?
Oncolytics Biotech (ONCY) has a current FCF Yield % of -19.84. The current FCF Yield % is -19.84. Oncolytics Biotech's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Oncolytics Biotech (ONCY), the current FCF Yield % is -19.84 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
31GF Score
Get the complete analysis for ONCY
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ONCY has been successfully added to your 
